Clinical approaches to the diagnosis of acute heart failure

Current Opinion in Cardiology

Volumn 22, Issue 3, 2007, Pages 207-213

  Wong, Graham C ^a,b,e   Ayas, Najib T ^a,b,c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c Providence Health Care   (Canada)

^d VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^e Gordon and Leslie Diamond Health Care Centre Vancouver Coastal Health   (Canada)

Author keywords

Congestive heart failure; Impedance cardiography; Natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART FAILURE; ARTIFICIAL HEART PACEMAKER; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; HEART FUNCTION; HUMAN; IMPEDANCE CARDIOGRAPHY; LUNG FLUID; MEDICAL DECISION MAKING; OUTPATIENT CARE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; TITRIMETRY;

ACUTE DISEASE; CARDIAC PACING, ARTIFICIAL; CARDIOGRAPHY, IMPEDANCE; DIAGNOSIS, DIFFERENTIAL; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN;

EID: 34147213586     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3280d357e1     Document Type: Review

References (26)

1. Bales AC, Sorrentino MJ. Causes of congestive heart failure. Prompt diagnosis may affect prognosis. Postgrad Med 1997; 101:44-46.
2. Wuerz RC, Meador SA. Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann Emerg Med 1992; 21:669-674.
3. Friedman MM. Older adults' symptoms and their duration before hospitalization for heart failure. Heart Lung 1997; 26:169-176.
4. Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003; 41:1797-1804.
5. Wang CS, FitzGerald JM, Schultzer M, et al. Does this dyspneic patient in the emergency department have congestive heart failure? J Am Med Assoc 2005; 294:1944-1956.
6. Felker GM, Petersen JW, Mark DB. Natriuretic peptides in the diagnosis and management of heart failure. CMAJ 2006; 175:611-617. This is an excellent concise summary of the potential clinical uses of natriuretic peptides.
7. Wang CS, FitzGerald JM, Schultzer M, et al. Does this dyspneic patient in the emergency department have congestive heart failure? J Am Med Assoc 2005; 294:1944-1956.
8. Januzzi JL, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95:948-954.
9. Baggish AL, Siebert U, Lainchbury JG, et al. A validated clinical and biochemical score for the diagnosis of acute heart failure. Am Heart J 2006; 151:48-54.
10. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2003; 41:571-579.
11. Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 2006; 47:91-97.
12. Wright SP, Doughty RN, Pearl A, et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart failure diagnosis in primary care. J Am Coll Cardiol 2006; 42:1793-1800. This was a well done randomized trial showing that amino-terminal probrain natriuretic peptide is useful in diagnosing heart failure in patients presenting to their general practitioner with dyspnea and/or peripheral edema.
13. Latour-Perez J, Coves-Orts FJ, Abad-Terrado C, et al. Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: A systematic review. Eur J Heart Fail 2006; 8:390-399. This comprehensive systematic review and meta-analysis showed that BNP is useful in identifying heart failure in dyspneic patients, but may not be useful in identifying ventricular dysfunction.
14. Ventura HO, Taler SJ, Strobeck JE. Hypertension as a hemodynamic disease: the role of impedance cardiography in diagnostic, prognostic, and therapeutic decision making. Am J Hypertens 2005; 18 (2 Pt 2):26S-43S.
15. Van De Water JM, Miller TW, Vogel RL, et al. Impedance cardiography: the next vital sign technology? Chest 2003; 123:2028-2033.
16. Bernstein DP. A new stroke volume equation for thoracic electrical bioimpedance: theory and rationale. Crit Care Med 1986; 14:904-909.
17. Luepker RV, Michael JR, Warbasse JR. Transthoracic electrical impedance; quantitative evaluation of a noninvasive measure of thoracic fluid volume. Am Heart J 1973; 85:83-93.
18. Van de Water JM, Mount BE, Barela JR, et al. Monitoring the chest with impedance. Chest 1973; 64:597-603.
19. Albert NM, Hail MD, Li J, et al. Equivalence of the bioimpedance and thermodilution methods in measuring cardiac output in hospitalized patients with advanced, decompensated chronic heart failure. Am J Crit Care 2004; 13:469-479.
20. Ziegler D, Grotti L, Krucke G. Comparison of cardiac output measurements by TEB vs. intermittent bolus thermodilution in mechanical ventilated patients [abstract]. Chest 1999; 116:218S.
21. Sageman WS, Riffenburgh RH, Spiess BD. Equivalence of bioimpedance and thermodilution in measuring cardiac index after cardiac surgery. J Cardiothorac Vasc Anesth 2002; 16:8-14.
22. Bhalla V, Isakson S, Bhalla MA, et al. Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients. Am J Hypertens 2005; 18 (2 Pt 2):73S-81S.
23. Packer M, Abraham WT, Mehra MR, et al. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol 2006; 47:2245-2252. This well done clinical trial describes the use of impedance cardiography to help identify CHF patients who are at risk for recurrent decompensation. ICG-derived hemodynamic variables had predictive power to predict acute decompensation over and above clinically derived variables.
24. Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005; 112:841-848.
25. Adamson PB, Smith AL, Abraham WT, et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 2004; 110:2389-2394.
26. Adamson PB, Kleckner KJ, VanHout WL, et al. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003; 108:266-269.